Hanna Y Irie
6PUBLICATIONS
48CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Mar 17, 2025
PGV001, a Multi-Peptide Personalized Neoantigen Vaccine Platform: Phase I Study in Patients with Solid and Hematologic Malignancies in the Adjuvant Setting.Mansi Saxena, Thomas U Marron, Julia Kodysh
|Mar 08, 2024
MARCH2, a Novel Oncogene-regulated SNAIL E3 Ligase, Suppresses Triple-negative Breast Cancer Metastases.Koichi Ito, Ibuki Harada, Criseyda Martinez
|Aug 04, 2021
Simultaneous CK2/TNIK/DYRK1 inhibition by 108600 suppresses triple negative breast cancer stem cells and chemotherapy-resistant disease.Katsutoshi Sato, Amol A Padgaonkar, Stacey J Baker
|Jul 01, 2020
PRKCQ inhibition enhances chemosensitivity of triple-negative breast cancer by regulating Bim.Jessica H Byerly, Elisa R Port, Hanna Y Irie
|Nov 24, 2017
PTK6 regulates growth and survival of endocrine therapy-resistant ER+ breast cancer cells.Koichi Ito, Sun Hee Park, Igor Katsyv
|Sep 25, 2016
PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells.Jessica Byerly, Gwyneth Halstead-Nussloch, Koichi Ito
Pageof 1
Frequent Collaborators
2 joint publications
Katsutoshi Sato
1 joint publications
Olga Rechkoblit
1 joint publications
Alison Bartkowski
1 joint publications
Aneel K Aggarwal
1 joint publications
Koichi Ito
1 joint publications
Ibuki Harada
1 joint publications
Criseyda Martinez
1 joint publications
EunJee Lee
1 joint publications
Elisa Port
1 joint publications
Jessica H Byerly
